Chamber and committees

Information on how many disabled interns each NHS Board has hired in each of the last three years is not centrally held.

I refer the member to the answer to question S6W-00315 on
17 June 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

To understand the effectiveness of the COVID-19 vaccines in preventing the development of long COVID, an individual first has to have had COVID-19 in the first place.

Therefore, the question really is effectiveness of vaccines in preventing the COVID-19 virus and subsequent long COVID. A study published by Public Health England on 22 May 2021, Vaccines highly effective against B.1.617.2 variant after 2 doses , demonstrates the high effectiveness levels of two doses of both AstraZeneca and Pfizer vaccines against the Delta variant.

Two doses offer good protection against the Delta variant at levels of 88% and 60% for Pfizer and AstraZeneca vaccines respectively after two weeks. This is compared to 93% and 66% against the Kent variant. One dose of either vaccine offers protection of 33% against Delta variant after three weeks, compared to 50% against the Kent variant.

This follows data published on 23 April 2021 by the University of Oxford and the Office for National Statistics which showed that one dose of either the Pfizer or AstraZeneca cut coronavirus cases by nearly two-thirds and were 74% effective against symptomatic infection.

Clinical trials have found that vaccination against COVID-19 further reduces the likelihood contracting long COVID even if an individual develops COVID-19. A paper published by the Tony Blair Institute on 18 June 2021, The Hidden Pandemic: Long Covid , states ‘vaccination also provides additional protection against long COVID: even if a vaccinated individual goes on to contract Covid-19, that person’s chances of developing Long Covid are reduced by a further 30 per cent in the most at-risk age group.’

Additionally, the vaccines have shown to also relieve symptoms of long COVID in people that already developed COVID-19. Yale School of Medicine stated on 12 April 2021, Why Vaccines May Be Helping Some With Long COVID , ‘as many as 30 to 40 per cent of those who get the vaccine have reported improvements to their symptoms.’

However, analysis by Professor Karl Friston, of University College London, suggests that changes in people’s behaviour after being vaccinated have reduced the vaccines’ ability to prevent infection . People who have “let their guards down” by dramatically reducing social distancing and other safety measures have put themselves at much higher risk of contracting COVID -19 and potentially developing long COVID, believes Professor Friston, who publishes a weekly Covid-modelling report and sits on the influential independent Scientific Advisory Group for Emergencies ( SAGE ).

I announced on the 18 June, the establishment of a Lived Experience Panel will be a key initial task for the Implementation Group.

The Scottish Government continues to work closely with universities and colleges to support the safe return of students for the next academic year. Recovery of additional costs for the provision of quarantine facilities in student accommodation for international students from red-list countries is currently one of the matters being discussed.

While it is reassuring that, during a further national COVID-19 lockdown in Q1 2021, once a decision to treat was made, cancer patients in NHS Forth Valley waited on average four days for treatment. However, the 62 day standard remains challenged and while the overall aim is to recover cancer waiting times performance, our priority - as the NHS continues to remobilise - remains ensuring that vital services are delivered safely to patients based on their clinical priority.

To support the improvement of cancer waiting times, we are now releasing an additional £10 million non-recurring revenue funding across NHS Scotland, of which £545,000 has been made available to NHS Forth Valley.

Recovery and Redesign: An Action Plan for Cancer Services was published on 9 December 2020. The Plan will ensure patients have access to the best possible treatment and care and is monitored and overseen by the National Cancer Recovery Group.

The Scottish Government is in weekly contact with NHS Forth Valley to ensure that patients referred with an urgent suspicion of cancer are moved through the pathway as quickly as possible based on clinical priority and plans are underway to review the boards implementation of the Scottish Government Effective Cancer Management Framework.

This question relates to operational matters that are the responsibility of the Scottish Court and Tribunals Service (SCTS) corporate body. The question has been passed to the Chief Executive of the SCTS who will reply in writing within 20 days

These funding allocations are subject to agreement by COSLA Leaders and will be confirmed shortly. This information will be published on the Scottish Government when it is available at the following link: https://www.gov.scot/policies/schools/teachers/

The Gateway Review team for the recent Gateway Review into Scotland’s Deposit Return Scheme interviewed representatives of the following:

• Circularity Scotland Ltd
• Food and Drink Federation Scotland
• Lidl
• Scottish Environment Protection Agency
• Scottish Environmental Services Association and Suez
• Scottish Government
• Scottish Grocers’ Federation and G101 Stores
• Scottish Retail Consortium
• Scottish Wholesale Association
• Tesco
• Zero Waste Scotland

It will be for the Scottish Environment Protection Agency as regulator of Scotland’s Deposit Return Scheme (DRS) to assess Circularity Scotland’s performance of its obligations under the DRS Regulations.

We are currently considering our approach to wider monitoring and evaluation of the operation of DRS.